Albumin is then released back into the bloodstream upon exocytosis and exposure to neutral blood pH. Conjugation or tight binding to albumin allows a drug to ‘piggyback’ this serum albumin endocytic recycling pathway, thereby extending half-life. Accordingly, there remains a need for safe and …
